Studies show increased costs for patients who undergo imaging; considerable annual ER charges

Low-dose OCP users also have increased incidence of pain or discomfort during or after climax

Largest increase seen for Hispanic men, at 5.6 percent annually from 2002 to 2009

Study examines variants in follicle stimulating hormone and its receptor

Innovative, satirical physician discusses the syndrome and antidote

Surgeon General talks about importance of bringing joy back into movement and medicine

Communities can raise their own leaders; may be key approach to change at community level

Minimally invasive procedure decreases blood flow, effectively shrinks enlarged prostate

Decrease in advanced disease risk is associated with increasing quintiles of toenail mineral

Review sees link between health care providers' physical activity level, counseling offered

Findings among men on any anticoagulant therapy while receiving docetaxel chemotherapy

But no change in overall mortality in men with prostate CA randomized to finasteride versus placebo

Elderly and black men at greatest risk of having aggressive prostate cancer

No adverse effect on kidney cancer-specific survival; lower risk of all-cause death, cardio event

For men with high-risk prostate cancer, no difference in outcomes with 18, 36 months therapy

Non-attendance linked to fewer side effects during treatment, negative sperm banking experience

Click to access a single page summary of the most significant study results and research announcements presented.

With over 400,000 jobs from top employers, you are sure to find the right job for you.